We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Walvax

News List

Bivalent HPV Vaccine of Walvax Approved for Marketing: Who Will be the Leader of the Market Valuing RMB 100 billion? Yefenghong
April 11, 2022
Bivalent HPV Vaccine of Walvax Approved for Marketing: Who Will be the Leader of the Market Valuing RMB 100 billion?
China's Walvax says has most participants for large mRNA COVID vaccine trial FirstWordPharma
January 28, 2022
An official at Walvax Biotechnology said the Chinese company has recruited most of the 28,000 participants needed for a large clinical trial of its mRNA COVID-19 vaccine candidate, as reported in Yahoo!News.
Internally-developed vaccines reportedly approved in China europeanpharmaceuticalreview
January 09, 2020
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers’ products.
A Glimpse of Existing Pattern of the Quadrivalent Influenza Vaccines en-cphi.cn
November 23, 2017
Another member is added to the queue of the Chinese-produced quadrivalent influenza vaccines (split virion) in clinical development.